home / stock / fh:cc / fh:cc news

FH:CC News and Press, FILAMENT HEALTH CORP. From 10/23/23

Stock Information
Company Name: FILAMENT HEALTH CORP.
Stock Symbol: FH:CC
Market: AQNC
Menu
FH:CC FH:CC Quote FH:CC Short FH:CC News FH:CC Articles FH:CC Message Board
Get FH:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
FH:CC - Magdalena Biosciences Initiates Preclinical Study to Evaluate Plant Extracts to Treat Depression, Anxiety, ADHD and Other Mental Health Indications

Magdalena Biosciences, a joint venture recently formed by Jaguar Health and Filament Health Corp., is focused on developing novel, natural prescription medicines derived from plants for mental health indications Magdalena launches corporate website SAN FRANCISCO, CA / ACCESSWIRE / ...
FH:CC - FILAMENT HEALTH ANNOUNCES HEALTH CANADA AUTHORIZATION FOR PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR OPIOID USE DISORDER

FILAMENT HEALTH ANNOUNCES HEALTH CANADA AUTHORIZATION FOR PHASE 2 CLINICAL TRIAL STUDYING BOTANICAL PSILOCYBIN FOR OPIOID USE DISORDER Canada NewsWire Filament-sponsored research will study its botanical psilocybin drug candidate, PEX010 VANCOUVER, BC , Oct. ...

FH:CC - FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY NEGEV CAPITAL

FILAMENT HEALTH CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT UNIT OFFERING LED BY NEGEV CAPITAL Canada NewsWire VANCOUVER, BC , Sept. 29, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE:7QS) (" Filament " or the " Company "), a...

FH:CC - Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD

Magdalena Biosciences is focused on developing novel, natural prescription medicines derived from plants for mental health indications Import of coca leaves was authorized by the Peruvian Health Authority SAN FRANCISCO, CA / ACCESSWIRE / September 21, 2023 / Jaguar Health, Inc. (NASD...
FH:CC - FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU

FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT OF COCA LEAF FROM PERU Canada NewsWire The import to Filament's Metro Vancouver facility was conducted in collaboration with the Peruvian government and facilitated by Filament Health and Ja...

FH:CC - FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA

FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA Canada NewsWire Reset Pharma has licensed Filament's botanical psilocybin drug candidate for a phase 2 clinical trial studying demoralization syndrome VANCOUVER, BC , Aug. 31, 2023 /CNW/ - F...

FH:CC - FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT

FILAMENT HEALTH AND NASDAQ-LISTED SPAC JUPITER ACQUISITION CORP. ANNOUNCE FILING OF SEC REGISTRATION STATEMENT Canada NewsWire VANCOUVER, BC , Aug. 15, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a...
FH:CC - FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A

FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A FILAMENT HEALTH ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS AND REFILES Q1 2023 INTERIM FINANCIAL STATEMENTS AND MD&A Canada NewsWire VANCO...

FH:CC - FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF TWO CLINICAL TRIALS STUDYING ITS BOTANICAL PSILOCYBIN DRUG CANDIDATE PEX010

FILAMENT HEALTH ANNOUNCES FDA APPROVAL OF TWO CLINICAL TRIALS STUDYING ITS BOTANICAL PSILOCYBIN DRUG CANDIDATE PEX010 Canada NewsWire The University of Washington and the University of California, Los Angeles have been approved to study PEX010 in clinical trials for me...

FH:CC - The Power Play by The Market Herald Releases New Interviews with Etruscus Resources, Filament Health and Lancaster Resources Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / July 25, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Etruscus Resources, Filament Health and Lancaster Resources discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapsho...
Previous 10 Next 10